An international phase 3 clinical trial found that a new targeted treatment, given in combination with a standard chemotherapy, extended survival for select patients with advanced gastric or gastroesophageal junction cancer.
Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators.
Members of the Weill Cornell Medicine Class of 2027 received their short white coats on Aug. 15 during the annual White Coat Ceremony, officially marking the beginning of their medical education.
Feuerstein has founded several digital health companies and is the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.
A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study co-led by researchers at Weill Cornell Medicine.
Current methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood, which has important implications for determining how harmful they could be to a host, according to a new report.
Heather Kolakowski, from the Cornell Institute for Healthy Futures, and industry specialists discuss sustainable and inclusive senior living in the Keynote “Affordable Senior Living: Challenges and Opportunities Ahead.”
Deborah Fowell, professor and chair of the Department of Microbiology and Immunology in the College of Veterinary Medicine, has received a five-year, $2.32 million MERIT award from the NIH to study the factors that help guide immune cells.
